Expanding Horizons: Antibody-Drug Conjugates in Non–Small Cell Lung Cancer

Article

Funded in part by Daiichi Sankyo. Content independently developed by OncLive®

Related Videos
Sarah Sammons, MD
Laura Spring, MD
Laura Spring, MD
Corey J. Langer, MD
John F. Lazar, MD
Rodolfo Bordoni, MD
Related Content
Clinical Decision Making in Advanced NSCLC without Actionable Mutations

Clinical Decision Making in Advanced NSCLC without Actionable Mutations

April 21st 2023
Article
BTK Inhibitors in MCL and CLL

BTK Inhibitors in MCL and CLL

March 10th 2023
Article
Where Do ADCs Fit Into the Treatment Paradigm for Patients With NSCLC?

Where Do ADCs Fit Into the Treatment Paradigm for Patients With NSCLC?

January 25th 2023
Article
Clinical Case Scenarios: Approaches to Treatment Decisions in Non-Small Cell Lung Cancer

Clinical Case Scenarios: Approaches to Treatment Decisions in Non-Small Cell Lung Cancer

January 25th 2023
Article
Advances in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Advances in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

December 22nd 2022
Article
Best Practices on Addressing Disparities and Practicing Multicultural Care in Myeloma

Best Practices on Addressing Disparities and Practicing Multicultural Care in Myeloma

December 12th 2022
Article